1. Home
  2. Nation
  3. “You don’t want citizens to get redressal”: SC reprimands states

“You don’t want citizens to get redressal”: SC reprimands states

By Saima Siddiqui 
Updated Date
“You don’t want citizens to get redressal”: SC reprimands states

New Delhi: The Supreme Court on Wednesday made some tough remarks on Covid-19 vaccine stating that all vacancies in the state consumer dispute redressal panels should be filled up within eight weeks.

Also Read :- PM Modi to meet 7 Indian Covid-19 vaccine manufacturers today

The top court also slammed the central government for delaying the process “Don’t dash the hopes of people”.

“You raise (their) hopes that they will get (the) redressal but then you don’t fulfil those. If you are asking (the) states to fill up vacancies then you also need to do that. You need to have requisite number of people to deal with the cases,” the top court told the central government.

Maharashtra, Andhra Pradesh, Bihar, Arunachal Pradesh, Meghalaya and Jharkhand were among the states that were slammed over the lackadaisical approach. “The way states are acting is unacceptable. You do not want citizens to get redressal,” the court said.

The state government in Bihar was told, “Some ‘mahurat’ (auspicious moment)’ has to be set for you to take steps to fill up the vacancies?”

Also Read :- Farmers have right to protest but can't block roads indefinitely tells SC

Selection committees have to be set up by the states within four weeks, and all existing and potential vacancies have to be advertised within two weeks. “If states don’t notify rules within two weeks, model rule by centre will automatically apply,” the court has said.

The court had taken suo motu cognizance of pending vacancies in district and state redressal commissions across India. A two-judge bench of Justices SK Kaul and Hemant Gupta had called the situation “surprising”.

The court had directed the central government to file a status report about the vacancies and infrastructure of these tribunals.

Further reading:
For the latest news and reviews, follow us on Facebook and Twitter ...